Discover 2,591 paid clinical trials in Illinois. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Illinois offers various clinical research options, including those for healthy volunteers interested in paid studies, as well as for individuals with specific health conditions. Leading research centers in Chicago, Plainfield, and Springfield are actively seeking participants, providing access to innovative treatments and personalized care.
Filter
1
Filter results
Results: 2,591
Parkinson's Foundation PD GENEration Genetic Registry
for
Parkinson's Disease
Location: Boston MA, Farmington CT, New York NY, Philadelphia PA,
Sponsor: Parkinson's Foundation
Sex: All
Age: 18+
Code: NCT04994015
Recruiting
StrokeNet Thrombectomy Endovascular Platform
for
Ischemic Stroke
Location: Boston MA, Providence RI, Hartford CT, New Haven CT,
Sponsor: Medical University of South Carolina
Sex: All
Age: 18+
Code: NCT06289985
Recruiting
Telehealth Implementation of Brain-Computer Interface
for
Amyotrophic Lateral Sclerosis, Stroke
Location: Chicago IL
Sponsor: Shirley Ryan AbilityLab
Sex: All
Age: 16 - 70+
Code: NCT05951556
Recruiting
A Multi-Modality Surveillance Program for Women at High Risk for Breast Cancer
for
Breast Cancer
Location: Chicago IL, La Jolla CA, Sacramento CA
Sponsor: University of Chicago
Sex: Female
Age: 25+
Code: NCT03729115
Recruiting
52 Week Study + 24-Month Long-Term Extension of Safety, PK, & Efficacy of XYOSTED® for Testosterone Replacement in Male Adolescents With Hypogonadism
for
Hypogonadism, Male
Location: Boston MA, Worcester MA, The Bronx NY, Philadelphia PA,
Sponsor: Halozyme Therapeutics
Sex: Male
Age: 12 - 17
Code: NCT06689085
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Comparison of EVAR and ESAR for Infrarenal Aortic Aneurysms With a Wide Proximal Neck
for
Aortic Aneurysm, Abdominal
Location: Stony Brook NY, New Brunswick NJ, Hershey PA,
Sponsor: Rijnstate Hospital
Sex: All
Age: 18+
Code: NCT05484115
Recruiting
KRT-232 in Combination With TL-895 for the Treatment of R/R MF and KRT-232 for the Treatment of JAKi Intolerant MF
for
Myelofibrosis, Post-PV MF, Post-ET Myelofibrosis,
Location: New York NY, Fort Lee NJ, Lake City FL, Birmingham AL,
Sponsor: Kartos Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT04640532
Phase 1, Phase 2, Recruiting
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
for
Multiple Myeloma
Location: New York NY, Newark DE, Fairfax VA, Chapel Hill NC,
A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer
for
HER2-positive Gastric Cancer,
Location: Chicoutimi, New York NY, Albany NY, Summit NJ, Montreal,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06764875
Phase 3, Recruiting
CCHS Secure Health-hub Advancing Research Efforts (CCHS SHARE)
for
Congenital Central Hypoventilation Syndrome
Location: Chicago IL
Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago
Sex: All
Age: 0+
Code: NCT06554275
Recruiting
Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk
for
Peripheral Arterial Disease, Atherosclerosis of Extremities,
Location: Rimouski, Boston MA, New Haven CT, New York NY,
Sponsor: Population Health Research Institute
Sex: All
Age: 18+
Code: NCT04774159
Phase 3, Recruiting
Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis
for
Multiple Sclerosis, Relapsing-Remitting
Location: Tampa FL, Louisville KY, Chicago IL, Milwaukee WI,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 10 - 17
Code: NCT06408259
Phase 3, Recruiting
Effects of TNF Blockade on Human BPH/LUTS
for
Benign Prostatic Hyperplasia (BPH)
Location: Glenview IL
Sponsor: Endeavor Health
Sex: Male
Age: 45 - 70+
Code: NCT06062875
Phase 2, Recruiting
Posaconazole (MK-5592) Intravenous and Oral in Children (<2 Years) With Invasive Fungal Infection (MK-5592-127)
for
Invasive Fungal Infection
Location: Chicago IL
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 0 - 2
Code: NCT04665037
Phase 2, Recruiting
A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)
for
Small Cell Lung Cancer
Location: Boston MA, Hackensack NJ, Miami FL, Buffalo NY,